← Back to Browse
ProductMedical Services and Publications

Clinical Consultation and Risk Stratification Service

China

Medical advisory service for cancer risk assessment and early detection strategy development. This service integrates diagnostic testing results with clinical decision support for patient management. The service is provided in collaboration with partner medical institutions.

Manufactured by

BioChain (Beijing) Science & Technology. Inc.

China

BioChain (Beijing) Science & Technology Inc. is a pioneer in cancer early diagnosis and screening in China. The company specializes in developing NGS and PCR-based cancer gene methylation detection products, focusing on early cancer diagnosis reagent kits and large-scale laboratory screening platforms.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
26 relevant products
2Germany
9 relevant products
3Spain
7 relevant products
🔒

20 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 75 closest product alternatives

75 products

72 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products